Assignee
APPLIED GENETIC TECH CORPORATION
US·1 granted patent·14 pending applications·0 citations·filing 2013–2023
Top patents by PatentIndex Score
15 records- 0160US2021171591A1Codon optimized nucleic acid encoding a retinitis pigmentosa gtpase regulator (rpgr)APPLIED GENETIC TECH CORPORATION·Filed 2020·Application pending·0 cites
- 0257US2021154325A1Promoters, expression cassettes, vectors, kits, and methods for the treatment of achromatopsia and other diseasesAPPLIED GENETIC TECH CORPORATION·Filed 2020·Application pending·0 cites
- 0355US2019017033A1Recombinant aav production in mammalian cellsAPPLIED GENETIC TECH CORPORATION·Filed 2018·Application pending·0 cites
- 0455US2024067984A1Triple function adeno-associated virus (aav)vectors for the treatment of c9orf72 associated diseasesAPPLIED GENETIC TECH CORPORATION·Filed 2023·Application pending·0 cites
- 0552US2017362577A1Recombinant aav production in mammalian cellsAPPLIED GENETIC TECH CORPORATION·Filed 2017·Application pending·0 cites
- 0650US2021147872A1Adeno-associated virus (aav) systems for treatment of progranulin associated neurodegenerative diseases or disordersAPPLIED GENETIC TECH CORPORATION·Filed 2020·Application pending·0 cites
- 0750US2019276507A1Codon optimized nucleic acid encoding a retinitis pigmentosa gtpase regulator (rpgr)APPLIED GENETIC TECH CORPORATION·Filed 2018·Application pending·0 cites
- 0849US2018312872A1Recombinant virus production using mammalian cells in suspensionAPPLIED GENETIC TECH CORPORATION·Filed 2017·Application pending·0 cites
- 0945US2021340503A1Recombinant aav production in mammalian cellsAPPLIED GENETIC TECH CORPORATION·Filed 2021·Application pending·0 cites
- 1044US9982275B2Promoters, expression cassettes, vectors, kits, and methods for the treatment of achromatopsia and other diseasesAPPLIED GENETIC TECH CORPORATION·Filed 2013·Granted May 29, 2018·0 cites·10 claims
- 1144US2018154022A1Promoters, expression cassettes, vectors, kits, and methods for the treatment of achromatopsia and other diseasesAPPLIED GENETIC TECH CORPORATION·Filed 2017·Application pending·0 cites
- 1244US2021147873A1Triple function adeno-associated virus (aav)vectors for the treatment of c9orf72 associated diseasesAPPLIED GENETIC TECH CORPORATION·Filed 2020·Application pending·0 cites
- 1341US2021123028A1Formulation optimization for viral particlesAPPLIED GENETIC TECH CORPORATION·Filed 2020·Application pending·0 cites
- 1441US2021123076A1Adeno-associated virus (aav)vectors for the treatment of age-related macular degeneration and other ocular diseases and disordersAPPLIED GENETIC TECH CORPORATION·Filed 2020·Application pending·0 cites
- 1537US2019002913A1Promoters, expression cassettes, vectors, kits, and methods for the treatment of achromatopsia and other diseasesAPPLIED GENETIC TECH CORPORATION·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when APPLIED GENETIC TECH CORPORATION files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →